TWO SIGMA INVESTMENTS, LP

Position in IBRX — ImmunityBio, Inc.

CIK 1179392 NEW YORK, NY

Position in IBRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$97,155,163

+$63,518,378 QoQ

Shares Held

11,097,106

+153.0% QoQ

Ownership

1.05%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

of 403 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. IBRX ranks #20 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$97,155,163	11,097,106	+153.0%	Shares	Sole	2026-08-14
2026-03-31	$33,636,785	4,385,500	-7.0%	Shares	Sole	2026-05-15
2025-12-31	$9,341,329	4,717,843	+80.9%	Shares	Sole	2026-02-17
2025-09-30	$6,415,335	2,607,860	+224.9%	Shares	Sole	2025-11-14
2025-06-30	$2,118,766	802,563	+3272.1%	Shares	Sole	2025-08-14
2025-03-31	$71,638	23,800	-16.0%	Shares	Sole	2025-05-15
2024-12-31	$72,491	28,317	-66.9%	Shares	Sole	2025-02-14
2021-06-30	$1,222,068	85,579	—	Shares	Sole	2021-08-16
2020-09-30 NK	—	617,599	+1596.8%	Shares	Sole	2020-11-16
2020-03-31 NK	—	36,398	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.